Sadra Medical

company

About

Sadra Medical is focused on developing minimal invasive alternatives to surgical valve replacement and improve patient care.

  • 10001 - max

Details

Last Funding Type
Series B
Last Funding Money Raised
$19M
Industries
Health Care,Medical Device
Founded date
Jan 1, 2003
Number Of Employee
10001 - max
Operating Status
Active

Sadra Medical is exploring new minimally invasive alternatives to traditional surgical valve replacement. The company hopes that devices allowing such procedural advances will facilitate and enhance treatment of aortic valve disease.

Sadra Medical is dedicated to developing innovative new therapies for the treatment of aortic valve disease. By developing minimally invasive alternatives to traditional surgical valve replacement, the company seeks to help improve patient care and make valve replacement possible for broader range of patients. Treatment of aortic valve disease remains a significant and growing unmet clinical need. As many as 3 million people in U.S. have aortic valve stenosis; however, only a small percentage of those are treated with the current standard of care, valve replacement during open-heart surgery using cardiopulmonary bypass. By developing a highly effective aortic valve replacement that is designed to reduce the risks and morbidity associated with open surgical valve replacement, Sadra Medical seeks to provide a therapeutic option for patients who are not being treated today.

Sadra Medical, a subsidiary of Boston Scientific.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$49M
Sadra Medical has raised a total of $49M in funding over 2 rounds. Their latest funding was raised on May 22, 2009 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 22, 2009 Series C $30M 1 Detail
Oct 23, 2006 Series B $19M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sadra Medical is funded by 1 investors. Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Series C